If a company builds assets at 13.4% a year, faster than its revenue growth rate of 11.8% over the past 5 years, it means that the company may be getting less efficient.
During the past 12 months, CSPC Pharmaceutical Group's average Total Assets Growth Rate was 16.50% per year.
During the past 3 years, the average Total Assets Growth Rate was 13.00% per year.
During the past 5 years, the average Total Assets Growth Rate was 13.40% per year.
During the past 10 years, the average Total Assets Growth Rate was 14.60% per year.
During the past 13 years, CSPC Pharmaceutical Group's highest 3-Year average Total Assets Growth Rate was 91.40%. The lowest was -36.00%. And the median was 12.70%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CSPC Pharmaceutical Group Total Assets Calculation
Total Assets are all the assets a company owns.
From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.
CSPC Pharmaceutical Group's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CSPC Pharmaceutical Group (HKSE:01093) Total Assets Explanation
Note:
The Net Income data used here is four times the quarterly (Dec. 2023) data.
In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.
Total Assets is linked to total revenue through Asset Turnover.
CSPC Pharmaceutical Group's Asset Turnover for the quarter that ended in Dec. 2023 is
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.
CSPC Pharmaceutical Group Total Assets Related Terms
Thank you for viewing the detailed overview of CSPC Pharmaceutical Group's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.
CSPC Pharmaceutical Group (HKSE:01093) Business Description
CSPC Pharmaceutical Group listed on the Hong Kong Stock Exchange in 1994 and is one of the largest pharmaceutical companies in China. Its biggest business segment is the finished drugs segment which accounts for nearly 80% of its total revenue. Now it has a diversified pipeline portfolio in seven therapeutic areas including nervous system diseases, oncology, anti-infective to cardiovascular disease, respiratory system disease, and metabolism. CSPC also has a bulk drug product segment including vitamin C, antibiotics, and a caffeine series.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HKSE:01093 has been successfully added to your 